These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29250038)

  • 21. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ
    Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D; Zaghian S; Khodabakhsh F; Fazeli H; Mobasherizadeh S; Ataei B
    J Microbiol Immunol Infect; 2014 Oct; 47(5):371-6. PubMed ID: 23838264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.
    Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A
    Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in
    Domokos J; Damjanova I; Kristof K; Ligeti B; Kocsis B; Szabo D
    Front Microbiol; 2019; 10():157. PubMed ID: 30809206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
    Oguri T; Igari J; Hiramatsu K; Watanabe A; Inoue M; Abe M; Yamane N; Aihara M; Hashimoto H;
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community.
    Rath S; Padhy RN
    J Infect Public Health; 2014; 7(6):496-507. PubMed ID: 24996691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group.
    Jones RN; Kehrberg EN; Erwin ME; Anderson SC
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):203-15. PubMed ID: 7851083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commensal Fitness Advantage May Contribute to the Global Dissemination of Multidrug-Resistant Lineages of Bacteria-The Case of Uropathogenic
    Fuzi M; Sokurenko E
    Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Present situation of antimicrobial resistance in Korea.
    Chong Y; Lee K
    J Infect Chemother; 2000 Dec; 6(4):189-95. PubMed ID: 11810564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis.
    Kohlenberg A; Schwab F; Meyer E; Behnke M; Geffers C; Gastmeier P
    J Hosp Infect; 2009 Nov; 73(3):239-45. PubMed ID: 19804919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Lee K; Park KH; Jeong SH; Lim HS; Shin JH; Yong D; Ha GY; Chong Y; KONSAR group
    Yonsei Med J; 2006 Feb; 47(1):43-54. PubMed ID: 16502484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. International dissemination of antibiotic resistant strains of bacterial pathogens.
    Witte W
    Infect Genet Evol; 2004 Sep; 4(3):187-91. PubMed ID: 15450197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
    Biedenbach DJ; Toleman M; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of vancomycin-resistant enterococci and extended-spectrum β-lactamase-containing Escherichia coli isolates in wild birds from the Azores Archipelago.
    Silva N; Igrejas G; Rodrigues P; Rodrigues T; Gonçalves A; Felgar AC; Pacheco R; Gonçalves D; Cunha R; Poeta P
    Avian Pathol; 2011 Oct; 40(5):473-9. PubMed ID: 21834624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in DNA Gyrase and Topoisomerase IV in Ciprofloxacin-Nonsusceptible Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.
    Park KS; Yang HS; Nam YS; Lee HJ
    Clin Lab; 2017 Mar; 63(3):535-541. PubMed ID: 28271673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
    Pfaller MA; Acar J; Jones RN; Verhoef J; Turnidge J; Sader HS
    Clin Infect Dis; 2001 May; 32 Suppl 2():S156-67. PubMed ID: 11320455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.